Service Description:

The University of Veterinary Medicine Vienna (Vetmeduni) offers the generation of novel genetically modified mouse lines using DNA microinjection, ES cell injection, e.g. for the generation of new knockout or knock-in mouse models. The service can include the design and generation of DNA micro fragments or ES cells. Mouse models could also be generated by using CRISPR/Cas9 technology that enables the modification of genome to produce precise and unique genetically modified mouse models. The service includes the design of guides and DNA template, preparation, and electroporation of the targeting complex into zygotes to generate F0 founder mutant animals (C57BL/6 genetic background preferred). Vetmeduni always try to minimise the off-target effects and increase the on-target effects of the guide RNAs. Selected F0 animals will be bred to germline to produce F1 genome edited animals. Possible allele types that can be generated are indels, exon deletions (< 5kb), point mutations, and small insertions. Newly developed mouse models will be made available to selected applicants within an average of 12 months following provision of all required information to start the mouse production. Novel models are archived as cryopreserved material and distributed as part of the EMMA archive. The price is calculated individually and depends on the scope of the service required for the generation of the desired mouse line.

Included in the Service:

  • Design of the injection fragment
  • Micro injection into zygotes
  • Design of the ES cells
  • ES cell injection into blastocysts
  • Design of the guides (crRNA+tracrRNA)
  • Design of ssODN or lsODN DNA templates,
  • Electroporation into zygotes
  • Genotyping of founders by sequencing of the target site
  • Breeding of founders (2-4 per line)
  • Genotyping of F1 mice by sequencing of the target
  • Organising the shipment of mice (two founder lines for each mutation), costs covered by the customer

Additional Support:

Vetmeduni can additionaly offer:

  • Breeding of animals in a specific pathogen free environment
  • Breeding of F1 animals (2-4) and genotyping of F2 generation.
  • Logistics support and advice to ship generated/re-derived mice to the receiving institute.
  • Dedicated shippers for transportation of frozen materials and recommendations on specialised courier services.
  • Recovery of EMMA-archived/customer-provided mouse lines from frozen materials.

How to apply for the INFRAFRONTIER Mouse Model Generation service?

Please click the button below to fill out our Service Request Form or Pbagnpg hf if you have any questions.

If you have a preferred service provider, please indicate it in the form.

Get to know the provider:

The Institute of in vivo and in vitro Models is responsible for the generation of mouse models for basic biomedical research in our Core Facility Platform VetBioModels (VBM) at the Vetmeduni Vienna. Our repertoire includes methods for the development of new genetically modified mouse models. We also archive, revitalise, and re-derivate mouse strains for basic biomedical research. The research group tries constantly to improve the methods used for gene editing and for developing genetically modified organisms. The VBM Core Facility and Institute of in vivo and in vitro Models at the Vetmeduni serve as the Austrian European Mouse Mutant Archive (EMMA) node, with about 300 publicly available mouse lines, and INFRAFRONTIER (www.infrafrontier.eu/) partner.

Learn more about Vetmeduni here.

Relevant Publications
  1. Ghorbanalipoor S, Hommel T, Kolbe T, et al. The loss of keratin 77 in murine skin is functionally compensated by keratin 1. Biochim Biophys Acta Mol Cell Res. 2024; Nov 25:119881. doi: 10.1016/j.bbamcr.2024.119881

  2. Hedegger K, Blutke A, Hommel T, et al. Trapping all ERBB ligands decreases pancreatic lesions in a murine model of pancreatic ductal adenocarcinoma. Mol Oncol. 2023; Nov;17(11):2415-2431. doi: 10.1002/1878-0261.13473

  3. Hedegger K, Algül H, Lesina M, et al. Unraveling ERBB network dynamics upon betacellulin signaling in pancreatic ductal adenocarcinoma in mice. *Mol Oncol. 2020;Aug;14(8):1653-1669. doi: 10.1002/1878-0261.12699

INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).